MHRA Class 4 Medicines Defect Notification: Co-Amoxiclav powder for oral suspension 250/62.5 mg/ml (Sandoz Limited)
MHRA Class 4 Medicines Defect Notification: Co-Amoxiclav powder for oral suspension 250/62.5 mg/ml (Sandoz Limited) Drug alert number: EL(26)A/46 Date issued: 05 November 2026 Sandoz Limited have informed the MHRA of errors in the dosing table in the Summary of Product Characteristics (SmPC) for Co-amoxiclav 250/62.5 mg/5 ml Powder for Oral Suspension. DMRC reference number: DMRC- [...]
The post MHRA Class 4 Medicines Defect Notification: Co-Amoxiclav powder for oral suspension 250/62.5 mg/ml (Sandoz Limited) appeared first on Community Pharmacy England.